In the current study, the authors investigated the relation between disease parameters in colon cancer patients which had not been investigated before we found that both miRNA34a gene expression and p53 gene expression were down regulated in patients with stage IV disease, grade III pathology and in patients with shorter time to progression. The gene discussed is TP53; the disease is colonic neoplasm.